tiprankstipranks
Comera Life Sciences Holdings (CMRA)
OTHER OTC:CMRA
US Market

Comera Life Sciences Holdings (CMRA) Income Statement

24 Followers

Comera Life Sciences Holdings Income Statement

Last quarter (Q3 2023), Comera Life Sciences Holdings's total revenue was $136.31K, a decrease of -41.98% from the same quarter last year. In Q3, Comera Life Sciences Holdings's net income was $-2.15M. See Comera Life Sciences Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20
Total Revenue
$ 844.28K$ 633.10K$ 0.00$ 0.00
Cost of Revenue
$ 158.48K$ -210.39K--
Gross Profit
$ 685.80K$ 422.71K--
Operating Expense
$ 6.77M$ -12.39M$ 1.05M$ 208.69K
Operating Income
$ -6.17M$ -11.97M$ -1.05M$ -208.69K
Net Non Operating Interest Income Expense
$ 9.20K$ -5.61M$ 37.68K$ 9.15K
Other Income Expense
$ -81.92K$ 800.52K$ 5.70M$ -3.08M
Pretax Income
$ -6.08M$ -18.38M$ 4.69M$ -3.28M
Tax Provision
$ 56.04K--$ 0.00
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ -6.13M$ -18.38M$ 4.69M$ -3.28M
Basic EPS
$ -0.31$ -1.76$ 0.35$ -0.61
Diluted EPS
$ -0.31$ -1.76$ 0.35$ -0.61
Basic Average Shares
$ 61.30M$ 10.45M$ 13.24M$ 13.24M
Diluted Average Shares
$ 61.30M$ 10.45M$ 13.24M$ 13.24M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 6.93M$ -12.60M$ 1.05M$ 208.69K
Net Income From Continuing And Discontinued Operation
$ -6.07M$ -18.38M$ 4.69M$ -3.28M
Normalized Income
$ -2.73M-$ -1.02M$ -199.53K
Interest Expense
----
EBIT
$ -6.09M$ -18.36M$ -1.05M$ -208.69K
EBITDA
$ -6.01M$ -18.26M$ -1.05M$ -208.69K
Currency in USD

Comera Life Sciences Holdings Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis